SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-03-000085
Filing Date
2003-02-13
Accepted
2003-02-13 12:39:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G e300062_sc13ga-lynx.txt SC 13G/A 9401
  Complete submission text file 0001193805-03-000085.txt   11191
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45862 | Film No.: 03557680
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)